Lv61
1895 积分 2021-11-18 加入
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
1小时前
待确认
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
3天前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
7天前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
8天前
已完结
A phase II study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first‐line therapy in patients with newly diagnosed, stage I–II extranodal natural‐killer/T‐cell lymphoma
14天前
已完结
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
15天前
已完结
Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation
22天前
已完结
CTLA-4: From mechanism to autoimmune therapy
22天前
已完结
Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)
22天前
已完结
T-DM1-induced thrombocytopenia in breast cancer patients: New perspectives
22天前
已完结
皖公网安备34019202002308
